1. Home
  2. MAIA

MAIA

MAIA Biotechnology Inc.

Logo MAIA Biotechnology Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 10:31am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Founded: 2018 Country:
United States
United States
Employees: N/A City: CHICAGO
Market Cap: 40.8M IPO Year: 2022
Target Price: N/A AVG Volume (30 days): 328.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.49 EPS Growth: N/A
52 Week Low/High: $0.82 - $4.25 Next Earning Date: 05-06-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: